ArticleTranslational lung cancer research2024
Imaging performance of thoracic SMARCA4-deficient undifferentiated tumor: a case report and literature review.
Article in Translational lung cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 2 citations in OpenAlex.
- A thoracic SMARCA4-deficient undifferentiated tumor: A case report.Oncology letters · 2026Article
- CT imaging features of pulmonary SMARCA4-deficient undifferentiated carcinoma: a retrospective case series.Frontiers in oncology · 2026Article
- Immune checkpoint inhibitors have limited efficacy inTranslational lung cancer research · 2025Article
- Review
- SMARCA4-deficient non-small cell lung cancer with metastasis to the sigmoid colon: a case report.World journal of surgical oncology · 2025Article
- Case Report: Synergistic multimodal therapy in SMARCA4-deficient undifferentiated tumor: integrating chemotherapy, anti-angiogenesis immunotherapy, and radiotherapy for enhanced outcomes.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) is a class of high-grade malignant tumors that has only been described in recent years, with an undifferentiated or rhabdoid morphology and genetic deletion of Case Description: Herein, we report a 51-year-old man who came to our hospital with multiple enlarged lymph nodes in the chest after a computed tomography (CT) examination at another hospital. The patient underwent conventional ultrasound (US), contrast-enhanced ultrasound (CEUS), magnetic resonance imaging (MRI), Conclusions: During this procedure, we obtained a series of relevant clinical and imaging data, especially US and CEUS images, which were described for the first time, offering valuable imaging information that will contribute to the clinical diagnosis of this disease to a certain extent. Moreover, this case highlights the efficacy of CEUS in identifying internal necrosis within tumors and lymph nodes, thereby improving the success rate of obtaining tumor tissue for pathological diagnosis. These findings substantiate the practical utility of US and CEUS in the context of mediastinal SMARCA4-UT, emphasizing their potential for widespread clinical adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.